The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 7, 1999, Pages 2489-2495

  Korbonits, Márta ^a   Kaltsas, Gregory ^b   Perry, Leslie A ^a   Putignano, Piero ^b   Grossman, Ashley B ^b   Besser, G Michael ^b   Trainer, Peter J ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; HEXARELIN; HYDROCORTISONE; PLACEBO; PROLACTIN;

ADULT; APPETITE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033305790     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.7.5811     Document Type: Article

References (56)

1. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats
2. 2 in rat primary pituitary cell monolayer culture
3. 2 in rats, dogs and monkeys
4. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: Evidence for non-GHRH-mediated responses
5. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects
6. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone
7. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, and oral administration in man
8. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6
9. The effect of an opiate antagonist on the hormonal changes induced by hexarelin
10. A receptor in pituitary and hypothalamus that functions in growth hormone release
11. On the in vitro and in vivo activity of a new synthetic heptapeptide that acts on the pituitary to specifically release growth hormone
12. 2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men
13. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents
14. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585
15. Growth hormone releasing activity of hexarelin in humans: A dose-response study
16. Effects of acute and repeated intravenous administration of L-692,585, a novel nonpeptidyl growth hormone secretagogue, on plasma growth hormone, ACTH, cortisol, prolactin, Thyroxin (T4), insulin and IGF-1 levels in beagles
17. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology
18. Growth hormone-releasing peptide and its analogues; novel stimuli to growth hormone release
19. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats
20. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth-hormone release are inhibited by central somatostatin action
21. 2) in rat anterior pituitary cells
22. GH-deficient dw/dw rats and lit/lit mice show increased fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol
23. Central actions of peptide and non-peptide growth hormone secretagogues in the rat
24. Effect of intravenous administration of growth hormone-releasing peptide on plasma growth hormone in patients with short stature
25. Blocked growth hormone-releasing peptide (GHRP-6)-induced growth hormone secretion and absence of the synergic action of GHRP-6 plus growth hormone-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level
26. Absence of growth-hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary-stalk transection
27. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosin 3',5'-monophosphate accumulation in rat pituitary cell culture
28. Human fetal pituitary expresses functional growth hormone-releasing peptide receptors
29. A comparison of the effect of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis
30. Vasopressin and its neurophysins
31. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
32. Effect of synthetic ovine corticotropin-releasing factor: Dose response of plasma adrenocorticotropine and cortisol
33. Hexarelin, a synthetic growth hormone-releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans
34. The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome
35. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome
36. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH
37. Opioid peptide and α-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man
38. Effect of MK-0677 on growth hormone, IGF-1 and cortisol in beagles before and after hypophysectomy
39. The effect of hypoglycaemia and hexarelin on growth hormone and cortisol release in patients with pituitary disease
40. Centrally administered vasopressin modifies stress hormone (cortisol, prolactin) secretion in sheep under basal conditions, during restraint and following intravenous corticotrophin-releasing hormone
41. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
42. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat
43. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6
44. Neuropeptide-Y and ACTH-immuno-reactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat
45. Neuropeptide-Y stimulates corticotrophin-releasing factor-41 release from the rat hypothalamus in vitro
46. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants
47. The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin and corticotrophin-releasing hormone from the rat hypothalamus in vitro
48. Involvement of corticotrophin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat
49. Corticotrophin-releasing hormone inhibition of growth hormone releasing hormone-induced growth hormone release in man
50. Dose-dependent inhibition of growth hormone (GH)-releasing hormone induced growth hormone release by corticotrophin-releasing hormone in prepubertal children
51. Effects of intravenous corticotrophin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man
52. 1998 Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion
53. New hypothalamic hormone, corticotrophin-releasing factor, specifically stimulates the release of adrenocorticotropic hormone and cortisol in man
54. Corticotrophin-releasing hormone does not inhibit growth hormone-releasing hormone-induced release of growth hormone in control subjects but it is effective in patients with eating disorders
55. Involvement of vasopressin in histamine- and stress-induced prolactin release: Permissive, mediating or potentiating role?
56. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?